---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-25-000096"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T13:59:13.790781+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve 400,000-share increase to GRI Bio's 2018 Equity Incentive Plan

## Summary
- Shareholders voted 48,362 to 17,889 (179 abstain) to approve the amendment; broker non-votes: 1,023,943.
- Plan increase: 400,000 additional shares of common stock reserved for issuance under the Amended and Restated 2018 Equity Incentive Plan.
- Approximately 43.67% quorum (1,090,373 of 2,496,800 eligible shares) was present at the virtual August 13, 2025 Annual Meeting.
- Directors Roelof Rongen and Camilla V. Simpson elected with 63,031 and 63,581 votes for, respectively (broker non-votes: 1,023,943 each).
- Ratification of WithumSmith+Brown as auditor: 1,072,167 for, 16,553 against, 1,653 abstain (no broker non-votes).

## SEC filing metadata
- accession: 0001824293-25-000096
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429325000096/0001824293-25-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429325000096/val-20250813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-25-000096
- JSON: https://secwatch.observer/filing/0001824293-25-000096.json
- Plain text: https://secwatch.observer/filing/0001824293-25-000096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.